Earnings Call Insights: Golub Capital BDC (GBDC) Q2 2026 Management View CEO David B. Golub said, "GBDC had a small loss for the quarter, about 1% of NAV, and that was primarily because of mark-to-market fair value write-downs," adding that "adjusted NII per share for the quarter was $0.34" and that "nonaccruals remain low in both absolute terms and relative to BDC industry peers." He framed the q...
Earnings Call Insights: Golub Capital BDC (GBDC) Q2 2026 Management View CEO David B. Golub said, "GBDC had a small loss for the quarter, about 1% of NAV, and that was primarily because of mark-to-market fair value write-downs," adding that "adjusted NII per share for the quarter was $0.34" and that "nonaccruals remain low in both absolute terms and relative to BDC industry peers." He framed the quarter’s loss as accounting-driven, stating, "we mark our loans to fair value every accounting period" and "this last quarter saw meaningful spread widening and that caused us to write down fair values even on our well-performing credits." Golub emphasized potential reversals in marks, saying, "The good news is that we currently think that most of this quarter's fair value write-down will reverse in future quarters," and characterized market conditions as shifting, stating, "We've moved from a market that for years was becoming more borrower-friendly to one that's now becoming more lender-friendly" with "wider spreads and more attractive deal terms." COO Timothy Topicz detailed the quarter’s earnings drivers and portfolio quality, saying, "approximately 89% of GBDC's investment portfolio at fair value remains in our highest performing internal rating categories" and "investments on nonaccrual status remained very low at just 1.4% of the total investment portfolio at fair value." He also said, "credit spread widening drove the majority of the $0.52 per share of net realized and unrealized losses, resulting in a $0.18 per share loss in the quarter." CFO Christopher Ericson described yield and funding dynamics, stating, "GBDC's investment income yield fell approximately 30 basis points sequentially to 9.7% annualized" and "our cost of debt ... decreased approximately 20 basis points to 5.2%, reflecting our approximately 80% floating rate debt funding structure," adding, "net-net, GBDC's weighted average net investment spread ... declined slightly." Outlook Management did not p...
In this article NVDA AMD HXSCL HXSCL SSNLF SSNLF SNDK MU Follow your favorite stocks CREATE FREE ACCOUNT Sanjay Mehrotra, president and chief executive officer of Micron Technology Inc., during a groundbreaking ceremony for the new Micron Technology Inc. semiconductor manufacturing facility in Clay, New York, US, on Friday, Jan. 16, 2026. Heather Ainsworth | Bloomberg | Getty Images Micron's histo...
In this article NVDA AMD HXSCL HXSCL SSNLF SSNLF SNDK MU Follow your favorite stocks CREATE FREE ACCOUNT Sanjay Mehrotra, president and chief executive officer of Micron Technology Inc., during a groundbreaking ceremony for the new Micron Technology Inc. semiconductor manufacturing facility in Clay, New York, US, on Friday, Jan. 16, 2026. Heather Ainsworth | Bloomberg | Getty Images Micron's historic rally continued on Tuesday, with shares of the memory maker surging 12%, lifting the company's market cap past $700 billion for the first time. The stock is now up 125% this year and 700% in the past 12 months, pushing Micron into the top 10 most valuable U.S. tech companies. Demand for memory has surged as the artificial intelligence boom has created insatiable demand that's led to a global shortage. Chipmakers like Nvidia and Advanced Micro Devices require large amounts of memory to power their high-performance AI processors. Micron, SK Hynix and Samsung make up almost the entire memory market. Stock Chart Icon Stock chart icon Micron one-day stock chart. Sandisk , a maker of solid-state drives that rely on what's known as NAND memory, also spiked on Tuesday, jumping 12%. The stock is up about sixfold this year. Micron announced Tuesday that it's started shipping its largest commercially available solid-state drive . Compared to traditional hard disk drives, SSDs allow more memory to be stored with lower power demands. Jeremy Werner, Micron's senior vice president of its core data center unit, said in the press release that the "breakthrough capacity gives data center operators a critical new lever to improve rack-level total cost of ownership, especially as power availability becomes a defining constraint for AI infrastructure scale." Memory makers have been unable to meet demand during the AI frenzy that began in late 2022 with the launch of ChatGPT. After Micron's second-quarter earnings report in March, CEO Sanjay Mehotra told CNBC that key customers are only gett...
Micron zooms past $700 billion market cap as rally in memory stocks accelerates CNBC Micron’s stock soars as new report throws cold water on the bear case: ‘This time is different.’ MarketWatch Micron Technology (MU) Hits All-Time High on Chip Demand Yahoo Finance
Micron zooms past $700 billion market cap as rally in memory stocks accelerates CNBC Micron’s stock soars as new report throws cold water on the bear case: ‘This time is different.’ MarketWatch Micron Technology (MU) Hits All-Time High on Chip Demand Yahoo Finance
On May 5, 2026, Kickstand Ventures, LLC filed with the SEC to report the sale of 472,534 shares of Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ) , an estimated $9.24 million transaction based on quarterly average pricing. According to a May 5, 2026, SEC filing , Kickstand Ventures, LLC reduced its holdings in Invesco BulletShares 2026 Corporate Bond ETF by 472,534 shares. The estimate...
On May 5, 2026, Kickstand Ventures, LLC filed with the SEC to report the sale of 472,534 shares of Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ) , an estimated $9.24 million transaction based on quarterly average pricing. According to a May 5, 2026, SEC filing , Kickstand Ventures, LLC reduced its holdings in Invesco BulletShares 2026 Corporate Bond ETF by 472,534 shares. The estimated value of the shares sold was $9.24 million based on the average closing price between January 1 and March 31, 2026. The fund’s BSCQ position was valued at $6.93 million at quarter-end, down from the previous filing. The Invesco BulletShares 2026 Corporate Bond ETF offers institutional and individual investors targeted exposure to investment grade corporate bonds maturing in 2026, combining the benefits of bond laddering with the liquidity and transparency of an ETF structure. The fund's strategy is designed to deliver a defined maturity profile and consistent income until termination in December 2026. Its competitive edge lies in its efficient portfolio construction, monthly rebalancing, and ability to provide a diversified, low-cost solution for fixed income allocation within a single security. Continue reading
peshkov/iStock via Getty Images U.S. gasoline inventories are falling and could approach historically low levels this summer as weaker imports and refinery shifts tighten supply, according to a Morgan Stanley report released Monday. The bank’s base-case outlook calls for inventories to drop to roughly 198 million barrels by late August. That would fall below the lows seen during the 2022 energy cr...
peshkov/iStock via Getty Images U.S. gasoline inventories are falling and could approach historically low levels this summer as weaker imports and refinery shifts tighten supply, according to a Morgan Stanley report released Monday. The bank’s base-case outlook calls for inventories to drop to roughly 198 million barrels by late August. That would fall below the lows seen during the 2022 energy crisis and mark the lowest seasonal level in modern records. Supply squeeze builds The tightening reflects ripple effects from global oil disruptions tied to tensions around the Strait of Hormuz, which are increasingly influencing U.S. fuel markets. Gasoline imports have plunged, hitting a record weekly low in early April. Morgan Stanley expects arrivals from Europe in May to remain well under the usual 3 million to 4 million barrels. At the same time, refinery output patterns are compounding the shortage. U.S. refiners have been prioritizing diesel and jet fuel production, where margins are stronger, at the expense of gasoline. Exports add pressure Exports have also remained elevated, further draining domestic supplies. Shipments through April exceeded year-earlier levels, driven by steady demand from Latin America, particularly Mexico, as well as parts of Europe. Prices reflect tight market Market pricing is already factoring in much of the supply strain. July gasoline margins are trading near $35 a barrel, not far from the roughly $40 level implied by Morgan Stanley’s inventory projections. The bank sees a balanced risk outlook. Continued geopolitical tension could lift margins another $10 to $15 a barrel, potentially revisiting peaks from 2022. On the other hand, a rebound in imports, easing tensions or signs of weaker demand could quickly push margins lower. More on Gasoline Futures, Brent Futures, etc. SPX Realized Skew Inverts As Traders Focus On Right Tail Commodities: Middle East Re-Escalation Pushes Oil Prices Higher Oil Spikes Rhyme Through Time Exxon warns oil mar...
manassanant pamai/iStock via Getty Images The last time I spoke about ADC Therapeutics SA ( ADCT ), it was with a Seeking Alpha article entitled " ADC Therapeutics: Continues To Make Strides With ZYNLONTA Targeting DLBCL ." With respect to this article, I mentioned that the company had achieved preliminary positive results from the phase 1b LOTIS-7 trial using ZYNLONTA in combination with Roche's ...
manassanant pamai/iStock via Getty Images The last time I spoke about ADC Therapeutics SA ( ADCT ), it was with a Seeking Alpha article entitled " ADC Therapeutics: Continues To Make Strides With ZYNLONTA Targeting DLBCL ." With respect to this article, I mentioned that the company had achieved preliminary positive results from the phase 1b LOTIS-7 trial using ZYNLONTA in combination with Roche's ( RHHBY ) approved bispecific antibody glofitamab [COLUMVI] for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma [r/r DLBCL]. At that time, I had given this stock a Strong Buy rating, and I'm going to maintain this rating. The first reason is because of what I just mentioned, which is the combination of ZYNLONTA with glofitamab to treat these patients with r/r DLBCL. This program remains on track in that update data from the ZYNLONTA combination yielded an objective response rate [ORR] of 89.8% in 49 efficacy-evaluable patients with a minimum follow-up period of 6 months. Not only that, but here are two milestones for investors to keep an eye on with respect to this program. These would be full data from this phase 1b LOTIS-7 study at a medical meeting and also publication of the very same data by the end of 2026. The beauty of this company is that what I mentioned above only includes the targeting of r/r DLBCL [2nd-line] patients based on ZYNLONTA [CD-19-directed antibody-drug conjugate] + bispecific antibody glofitamab [COLUMVI]. The point is that the company is further along with another combination targeting this very same group of patients. This would be in terms of the phase 3 confirmatory LOTIS-5 trial evaluating ZYNLONTA in combination with rituximab [RITUXAN] for the treatment of these patients with r/r DLBCL. Top-line data from this late-stage study is expected in Q2 of 2026, and then final data is then anticipated by the end of this year. Should the company be successful at both time points, then it will be able to file a supplemen...
Revelation comes after report commissioned by department released in response to charity’s FoI request The Ministry of Defence has no system for examining whether UK military action has killed or injured civilians in war, a study commissioned by the department has revealed. The MoD also “does not maintain a central register of civilian harm incidents or allegations” and, despite mass casualties ca...
Revelation comes after report commissioned by department released in response to charity’s FoI request The Ministry of Defence has no system for examining whether UK military action has killed or injured civilians in war, a study commissioned by the department has revealed. The MoD also “does not maintain a central register of civilian harm incidents or allegations” and, despite mass casualties caused by other countries, has concluded there is no need to do so because its existing mitigation is considered effective. Continue reading...
Risk assets and momentum plays were shining on Tuesday. Exchange-traded funds focused on momentum, growth, risk, and small-caps were among the top performing strategies, posting gains of 1.6% or more.
Risk assets and momentum plays were shining on Tuesday. Exchange-traded funds focused on momentum, growth, risk, and small-caps were among the top performing strategies, posting gains of 1.6% or more.